Nivolumab: Does the Extended CheckMate-274 Results Prove It’s the Ultimate for MIBC? ASCO GU 2025 ASCO GU 3 Mins Read Extended CheckMate-274 Results Show Continued Benefit With Nivolumab in MIBC Date: February 14, 2025 Author: Dr. Matthew I. Milowsky, MD,…
Durvalumab / Imfinzi Defies Expectations in MIBC, Offering Survival Gains Beyond Complete Response in NIAGARA Trial – ASCO GU 2025 ASCO GU 3 Mins Read Transforming MIBC Treatment: Insights from the NIAGARA Trial Posted on February 16, 2025 The landscape of treating muscle-invasive bladder cancer…
